Valued at $458.5M at its early-stage round, Jan 2026. Nothing has traded since.
- ·The complete investor list: 17 names
- ·Watch Diagonal Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Diagonal Therapeutics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Early Stage VC (Series B) | $125.0M | ▮ | ▮ |
| Apr 2024 | Early Stage VC (Series A) | $128.0M | ▮ | ▮ |
Membership and data by Private Market View
Diagonal Therapeutics valuation
Diagonal Therapeutics was valued at $459 million at its early-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Diagonal Therapeutics raised?
Diagonal Therapeutics has raised $271 million across 2 recorded rounds since 2024. The largest was a $128 million Series A in Apr 2024; the most recent was a $125 million Series B in Jan 2026.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Rivus Pharmaceuticals ($489 million), Electra Therapeutics ($479 million) and CORXEL Pharmaceuticals ($475 million).
How Diagonal Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Diagonal Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Diagonal Therapeutics
- What is Diagonal Therapeutics worth?
- Diagonal Therapeutics is valued at $458.5M as of Oct 2026. Valued at $458.5M at its early-stage round, Jan 2026. Nothing has traded since.
- How much has Diagonal Therapeutics raised?
- Diagonal Therapeutics has raised $271.3M in total funding across 2 recorded rounds.
- When did Diagonal Therapeutics last raise?
- Diagonal Therapeutics last raised in Jan 2026 (Early Stage VC (Series B)), raising $125.0M.